Association of T and non-T cell cytokines with anhedonia: Role of gender differences

• Type of Material: Article
• Authors: Manish K. Jha, University of Texas Southwestern Medical Center; Andrew H Miller, Emory University; Abu Minhajuddin, University of Texas Southwestern Medical Center; Madhukar H. Trivedi, University of Texas Southwestern Medical Center
• Language: English
• Date: 2018-09-01
• Publisher: Elsevier
• Publication Version: Author Accepted Manuscript (After Peer Review)
• Copyright Statement: © 2018 Published by Elsevier Ltd.
• License: Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1016/j.psyneuen.2018.05.017
• Title of Journal or Parent Work: Psychoneuroendocrinology
• ISSN: 0306-4530
• Volume: 95
• Start Page: 1
• End Page: 7
• Grant/Funding Information: The CO-MED trial was funded by National Institute of Mental Health under contract N01 MH-90003 to the University of Texas Southwestern Medical Center at Dallas (Principal Investigators, M. H. Trivedi, and A.J. Rush).; This work was also supported in part through the Center for Depression Research and Clinical Care at UT Southwestern (Principal Investigator: Madhukar H. Trivedi, MD) and Hersh Foundation.
• Keywords: PSYCHOMETRIC EVALUATION; Science & Technology; Anhedonia; Endocrinology & Metabolism; BUPROPION-SSRI COMBINATION; QUICK INVENTORY; Gender; SEX-DIFFERENCES; DEPRESSIVE SYMPTOMATOLOGY; Psychiatry; Interleukin 17; INTERFERON-ALPHA; REPORT QIDS-SR; MAJOR DEPRESSION; Depression; C-REACTIVE PROTEIN; Neurosciences; Life Sciences & Biomedicine; IMMUNE-SYSTEM; Neurosciences & Neurology; Inflammation
• Research Categories: Psychology, Clinical; Health Sciences, Mental Health

Abstract

Objective: Among individual depressive symptoms, anhedonia has been reliably associated with activation of the innate immune response. However, it is unclear whether this association extends to T cell cytokines and if gender differentially affects this association. Method: Concentrations of T (IL-17, T-helper (Th) 1- and Th2-) and non-T cell cytokines were measured in plasma using the Bioplex Pro™ human cytokine multiplex kit in Combining Medications to Enhance Depression Outcomes (CO-MED) trial participants who provided plasma at baseline (n = 166). Anhedonia was measured with three items of the clinician-rated Inventory of Depressive Symptomatology and depression severity (minus anhedonia item) was measured with Quick Inventory of Depression Severity Self-Report version (modified-QIDS-SR). Separate generalized linear models for anhedonia and modified-QIDS-SR as dependent variables were conducted with IL-17, Th1-, Th2-, and non-T cell- cytokines as primary independent variables and gender, body mass index (BMI), and age as covariates. Exploratory analyses included gender-by-biomarker interactions. Results: Higher levels of IL-17 (p = 0.032), Th1- (p = 0.002), Th2-(p = 0.001) and non-T-(p = 0.009) cell markers were associated with greater severity of anhedonia controlling for BMI, age, and gender. Gender also had a significant main effect on anhedonia, however, there was a significant gender by immune marker interaction only for IL-17 (p = 0.050). Anhedonia severity increased with higher IL-17 in males (r = 0.42, p = 0.003) but not in females (r = 0.09, p = 0.336). Only non-T cell markers were associated with the modified-QIDS-SR, and there were no significant gender-specific associations with this variable. Conclusions: T and non-T cell-related inflammatory markers were associated with greater severity of anhedonia, while gender moderated the association of IL-17 with anhedonia in patients with major depressive disorder.